B. Lawrence Riggs, M.D.; Heinz W. Wahner, M.D.
This content is PDF only. Please click on the PDF icon to access.
During the last 6 years the development of methods that measure bone mineral density accurately at important sites of fracture represents a real advance in care of patients with osteoporosis, a disease costing $7 to $10 billion annually in the United States (1). The bone mineral density of the axial skeleton, formerly only crudely estimated from roentgenograms can now be measured with a precision of 2% to 3% by dual photon absorptiometry for the vertebrae or proximal femur (2) and of 3% to 5% by quantitative computed tomography for the vertebrae (3). Precision is defined as (standard deviation of replicate
Riggs BL, Wahner HW. Bone Densitometry and Clinical Decision-Making in Osteoporosis. Ann Intern Med. 1988;108:293–295. doi: 10.7326/0003-4819-108-2-293
Download citation file:
© 2019
Published: Ann Intern Med. 1988;108(2):293-295.
DOI: 10.7326/0003-4819-108-2-293
Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by: